Serum markers for prognostic value of EGFR-TKI in lung adenocarcinoma with bone metastases: a retrospective study

Background Lung adenocarcinoma is a prevalent malignancy. Mutations in the epidermal growth factor receptor (EGFR) have introduced novel prospects for targeted therapies. However, the status of EGFR mutations alone may be insufficient to fully predict treatment outcomes. To this end, the present res...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Jiali Li, Shuting Wang, Zhiyong Deng, Lu Zhang, Min Liu, Yunlei Luo, Yunqiu Guo, Pengjie Liu, Chao Liu
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PeerJ Inc. 2026-01-01
Edice:	PeerJ
Témata:	Lung adenocarcinom Serum markers EGFR-TKI Bone metastases Prognostic prediction
On-line přístup:	https://peerj.com/articles/20537.pdf
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!